Journals on the Web Barra Menu Home Subscription information Contact form Instructions for authors About the Journals on the Web Sample area Mailing list


Drugs of the Future

Available issues

 

Prous Science Home Page


Drugs of the Future

Vol. 25, No. 7, July 2000

Monographs

CDP-571. Treatment of IBD, Anti-TNF-a MAb. L.A. Sorbera, L. Martín, P.A. Leeson
HTML (28 Kb) PDF (63 Kb)

Cilengitide. Oncolytic, Angiogenesis inhibitor, Integrin avb 3,avb5 antagonist. L.A. Sorbera, A. Graul, J. Castañer
HTML (21 Kb) PDF (76 Kb)

Ezetimibe. Hypolipidemic, Cholesterol absorption inhibitor. R.M. Castañer, L.A. Sorbera, J. Castañer
HTML (27 Kb) PDF (103 Kb)

Gemtuzumab Ozogamicin. Treatment of acute myeloid leukemia. X. Rabasseda, A. Graul, R.M. Castañer
HTML (27 Kb) PDF (91 Kb)

Tiotropium Bromide. Treatment of COPD, Bronchodilator, Muscarinic antagonist. P. Norman, A. Graul, X. Rabasseda, J. Castañer
HTML (27 Kb) PDF (76 Kb)

Review Articles

Nitric oxide donor drugs. I.L. Megson
HTML (100 Kb) PDF (160 Kb)

Small molecule inhibitors of Src family kinases. D.H. Boschelli, F. Boschelli
HTML (134 Kb) PDF (176 Kb)

Information Update 1-24
AK-2123
Basiliximab
Bucindolol Hydrochloride
Candesartan Cilexetil
Celecoxib
Cisapride Hydrate
Daptomycin
Dexloxiglumide
Egualen Sodium
Emivirine
Entocapone
Esonarimod
Foscarnet Sodium
Frovatriptan
Ginkgolide B
Idebenone
Imidapril Hydrochloride
Imitrodast Sodium
INS-365
Lesopitron Dihydrochloride
Levofloxacin
Lomefloxacin Hydrochloride
Moguisteine
Nifedipine
NS-398
Oltipraz
Pentostatin
Phentolamine Mesilate
Prucalopride
Quercetin
Raloxifene Hydrochloride
Ramoplanin
Repaglinide
Risedronate Sodium
Ritonavir
Rivastigmine Tartrate
Rizatriptan Benzoate
Robalzotan Tartrate Hydrate
Roxifiban Acetate
Saredutant
Stearyl-Nle-VIP
Tolterodine Tartrate
Triptolide
Vatanidipine Hydrochloride
Zileuton

HTML (315 Kb) PDF (406 Kb)
Home | Subscription Information | Contact Form | Instructions for Authors |
About Journals on the Web | Sample Area | Mailing List

Copyright 1995-2008 Prous Science.
All rights reserved.
Legal Information.
Send your comments to Webmaster.